PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis |
| Phenotype | |liver disease |
| Sentences | 177 |
| PubMedID- 22760654 | liver disease due to chronic hepatitis b virus (hbv) and hepatitis c virus (hcv) infection is now emerging as an increasing cause of morbidity and mortality in human immunodeficiency virus- (hiv-) infected persons in resource-limited settings (rls). |
| PubMedID- 24742271 | Most of these infections cause chronic hepatitis and leading to progressive liver disease including cirrhosis, fibrosis and finally hepatocellular carcinoma (hcc) [3-5]. |
| PubMedID- 25805611 | A 51 years old male patient with end stage liver disease due to chronic hepatitis c virus infection received a right hemi-liver graft from his brother. |
| PubMedID- 24723944 | Had underling liver disease with mostly hepatitis c virus (hcv) serologically positive (123/271, 45.4%) but not with hbv (78/271, 28.8%); however, the patients in our study were most hbv serologically positive (312/413, 75.5%). |
| PubMedID- 24348771 | Serum samples from 90 patients with various liver diseases due to hepatitis b virus (hbv) infection were used for a competitive reaction with eu3+-halr. |
| PubMedID- 24036007 | As we designed a study for all-comers for liver biopsy, patients with vascular liver pathology (e.g., hepatic venous outflow obstruction) or acute hepatitis in patients with chronic liver disease, who would be expected to have higher ct1 due to liver congestion or inflammation, were also included. |
| PubMedID- 21465340 | Other severe acute complications have been reported since 2005: myocarditis [36], fulminant hepatitis in patients with chronic liver diseases [11], pancreatitis, acute endocrine disorders [37], extensive epidermolysis [11], kidney failures, respiratory failures, and decompensation of cardiovascular diseases [34]. |
| PubMedID- 25801076 | Background: the pnpla3/adiponutrin rs738409 c/g single nucleotide polymorphism is associated with the severity of steatosis, steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease, as well as the severity of steatosis and fibrosis in patients with chronic hepatitis c (chc). |
| PubMedID- 22619486 | Reported on 3 patients suffering from sp after liver transplantation, namely, two 42- and 62-year-old males with end-stage liver disease due to hepatitis c infection without significant other past medical or surgical history and a 59-year-old alcoholic. |
| PubMedID- 23630437 | Status of essential trace minerals and oxidative stress in viral hepatitis c patients with nonalcoholic fatty liver disease. |
| PubMedID- 20367803 | liver disease due to hepatitis c virus (hcv) infection is a leading cause of non-aids-related morbidity and mortality in patients infected with hiv. |
| PubMedID- 19910122 | Hcc most commonly develops in patients with chronic liver disease, the etiology of which includes viral hepatitis (b and c), alcohol, obesity, iron overload and dietary carcinogens, including aflatoxins and nitrosamines. |
| PubMedID- 26226455 | liver disease associated with persistent hepatitis b virus (hbv) infection represents a major health problem with global impact. |
| PubMedID- 22537436 | Noninvasive methods to assess liver disease in patients with hepatitis b or c. |
| PubMedID- 25457210 | Background & aims: genetic variants of patatin-like phospholipase domain-containing 3 (pnpla3) and diabetes are associated with liver disease severity, in patients with chronic hepatitis c (chc) infection. |
| PubMedID- 25339354 | The 13c-galactose bt has also been used to assess progressive decline in liver mass function in patients with chronic liver disease due to hepatitis c virus (hcv) infection [17]. |
| PubMedID- 21849046 | In one of the studies, mmp-9 levels were negatively correlated to the histological severity of the liver disease in patients with chronic hepatitis c [63]. |
| PubMedID- 23923056 | Therefore, the objectives of this study were: (1) to evaluate adherence to hepatitis vaccination guidelines in patients with chronic liver disease at a tertiary care hepatology clinic, (2) to identify barriers to vaccinations in patients with chronic liver disease, and (3) to determine physician variability in adherence to vaccination guidelines. |
| PubMedID- 26058465 | Persistent hbv infection can promote liver disease, thereby leading to hepatitis and cirrhosis [29]. |
| PubMedID- 23752047 | Overlap syndromes are biochemical, serological, histological and radiological overlaps across the classic autoimmune liver diseases in the presence of autoimmun hepatitis and primary biliary cirrhosis or primary sclerosing cholangitis. |
| PubMedID- 23213601 | 46-year-old female patient whose blood group was “a1 positive” underwent deceased donor liver transplantation (ddlt) from identical blood group donor for end-stage liver disease due to hepatitis c with meld score of 26. pre-operatively, she had comorbidities in the form of diabetes mellitus and recurrent hepatic hydrothorax requiring frequent therapeutic aspiration. |
| PubMedID- 25030555 | Association between gene polymorphisms of connective tissue growth factor and the progression of chronic liver disease associated with hepatitis c. |
| PubMedID- 25532128 | The mechanisms whereby hdv leads to accelerated liver disease in hepatitis b virus (hbv)/hdv co-infected patients and the histological characteristics of chronic hepatitis d (chd) patients need further investigation. |
| PubMedID- 24455227 | In addition, cytokine gene polymorphisms have been reported to be associated with liver disease severity in patients with viral hepatitis [10, 25] besides their impact on the cytokines production capacity [32–34]; therefore, heterogeneity of the candidate gene in hbv-infected patients serves as a probable biomarker for influence the disease phenotypes. |
| PubMedID- 25288416 | We found nationwide trends in increasing morbidity and medical costs for advanced liver disease associated with hepatitis c. |
| PubMedID- 20461127 | [18], francetwo double-blind, placebo controlled trials to investigate the safety and tolerability of two dosing regimens of adv (10 mg daily or 30 mg daily), 48-wk follow-up.n = 515 in the 10-mg study and 185 in the 30-mg study, chronic hepatitis b patients with compensated liver disease not undergoing treatment with evidence of viral replication.no overall median change from baseline in serum creatinine or phosphorus levels in 10 mg group. |
| PubMedID- 22681852 | Although several chronic liver diseases are associated with hcc, hepatitis b virus (hbv) and hepatitis c virus (hcv) statistically are the most commonly implicated risk factors. |
| PubMedID- 20678018 | End-stage liver disease due to hepatitis c virus infection (hcv) is the principal indication for liver transplantation. |
| PubMedID- 21145859 | Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis c patients with minimal liver disease. |
| PubMedID- 24069490 | These criteria also include symptoms of severe liver disease due to viral hepatitis a, b, c, and e (jaundice, hepatic encephalopathy, bleeding due to impaired synthesis of coagulation factors, and renal failure due to hepatorenal syndrome). |
| PubMedID- 22989301 | Background and aim: non-alcoholic fatty liver disease (nafld) overlapping with chronic hepatitis b virus (hbv) infection is undergoing a rapid increase in china. |
| PubMedID- 22087108 | It can cause cryptogenic liver disease, acute exacerbation of chronic hepatitis b, or even fulminant hepatitis and development of hepatocellular carcinoma [10]. |
| PubMedID- 24351813 | Several reports also noted the increased levels of gp73 expression in chronic liver disease in patients with acute hepatitis of various etiologies, chronic hepatitis c virus (hcv) infection and alcoholic liver disease. |
| PubMedID- 21809486 | The purpose of this study was to determine the serum level of oxidized low-density lipoprotein (ox-ldl), and evaluate its association with different clinically valuable parameters of liver disease in patients with chronic hepatitis c. |
| PubMedID- 21645344 | In this article we discuss several liver conditions which are directly affected by overweight and obese status, including non-alcoholic fatty liver disease, chronic infection with hepatitis c virus and post-liver transplant status. |
| PubMedID- 25088088 | Background and aim: assessment of the severity of liver disease following infection with hepatitis c virus (hcv) is important in treatment selection and prognosis. |
| PubMedID- 19447449 | [fatal acute hepatitis and cholestasis associated with liver disease]. |
| PubMedID- 20713178 | Prevalence and challenges of liver diseases in patients with chronic hepatitis c virus infection. |
| PubMedID- 22030902 | Risk for future clinical outcomes is proportional to the severity of liver disease in patients with chronic hepatitis c virus (hcv). |
| PubMedID- 26138651 | Background: rising rates of obesity, diabetes mellitus (dm), and nonalcoholic fatty liver disease among patients with chronic hepatitis c virus infection (hcv) may contribute to more rapid disease progression. |
| PubMedID- 21957404 | Fifteen patients suffered from end-stage liver disease due to hepatitis c; 7, due to hepatitis c with hepatocellular carcinoma; and the remaining 3, due to hepatocellular carcinoma with negative viral markers. |
| PubMedID- 26090677 | Some reports have shown that the incidence of severe hepatitis is high in patients with underlying chronic liver disease and those older than 40 years [11,12]. |
| PubMedID- 23799218 | Among heavy drinkers with liver disease, the development of severe alcoholic hepatitis (ah) is a serious complication. |
| PubMedID- 23226395 | liver disease due to hepatitis c virus (hcv) infection is an important health problem worldwide. |
| PubMedID- 22970270 | Eligible patients were ≥18 years of age, had compensated liver disease due to chronic hepatitis c virus (hcv) infection (any fibrosis stage, including compensated cirrhosis), detectable plasma hcv rna levels, and had received no previous treatment for hepatitis c. patients were excluded if they were co-infected with human immunodeficiency virus or hepatitis b virus or had any other cause of liver disease, severe depression or psychiatric disorder, or active substance or alcohol consumption >20 g/day in the last five years, as evaluated by a questionnaire. |
| PubMedID- 23241078 | The economic burden of advanced liver disease among patients with hepatitis c virus: a large state medicaid perspective. |
| PubMedID- 22544466 | Background: acute hepatitis (ah) in patients with chronic alcoholic liver disease is associated with high mortality. |
| PubMedID- 22012714 | The virologic determinants of progressive liver disease associated with hepatitis b virus (hbv) remain unclear. |
| PubMedID- 20549958 | It was concluded that, our data would be helpful in the diagnosis and management of patients with chronic liver diseases due to viral hepatitis in our region. |
| PubMedID- 25737729 | However, there is no data supporting the association between periodontal disease and patients with liver diseases associated with hepatitis c virus (hcv) and/or hepatitis b virus (hbv) infection. |